PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome
NCT: NCT04811287 · TERMINATED
Brief Summary
This study assesses the potential benefit of adjuvant platelet-rich plasma (PRP) with carpal tunnel release (CTR) for patients with severe carpal tunnel syndrome (CTS). CTR is a rather common procedure performed and seems to be quite effective for those with moderate CTS, but a number of patients with severe CTS do not have quite the same response post-CTR. The investigators will recruit patients who fall into the severe CTS category and compare CTR with and without adjuvant PRP to see if PRP can improve outcomes of this common surgery.
Frequently Asked Questions
What is PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome?
PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome is a clinical trial registered under NCT04811287. Current status: TERMINATED.
What is the status of NCT04811287?
The current status of NCT04811287 (PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome) is: TERMINATED.
When did PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome start?
PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome started on 2021-10-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.